Kelyniam Global, Inc.
KLYGOTCHealthcare● Active
$0.14
+$0.00(+0.00%)
Market Cap$1764000
P/E Ratio—
52W High$0.3
52W Low$0.05
Kelyniam Global, Inc.（KLYG）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · KLYG · 截至 2026-06-15
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.14M) | ($0.92M) | ($0.22M) | ($0.10M) | $0.20M |
| Depreciation & Amort. | $0.05M | $0.05M | $0.05M | $0.05M | $0.04M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.08M | $0.17M | $0.00M |
| Change in Working Capital | ($0.17M) | $0.17M | $0.18M | ($0.12M) | ($0.23M) |
| Net Cash from Operations | ($0.19M) | $0.10M | ($0.10M) | ($0.03M) | $0.12M |
| Investing Activities | |||||
| Capital Expenditure | $0.00M | ($0.01M) | $0.00M | ($0.05M) | ($0.01M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | $0.00M | ($0.01M) | $0.00M | ($0.05M) | ($0.01M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.15M | ($0.20M) | $0.13M | $0.01M | ($0.13M) |
| Net Cash from Financing | $0.15M | $0.05M | $0.10M | $0.08M | ($0.11M) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.19M) | $0.10M | ($0.10M) | ($0.08M) | $0.11M |
| FCF Margin %(computed) | -6.35% | 2.91% | -3.58% | -2.77% | 4.27% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · USD · M
深入了解Kelyniam Global, Inc.
关于Kelyniam Global, Inc.（KLYG）现金流量表
Kelyniam Global, Inc. 2025财年经营活动现金流($0.00B)，自由现金流($0.00B)（FCF利润率-6.35%），资本支出$0.00B。
常见问题
KLYG · 4 问Kelyniam Global, Inc. 2025财年自由现金流($0.00B)，同比down299.8%。
KLYG free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15